78. Hypopituitarism Clinical trials / Disease details


Clinical trials : 494 Drugs : 385 - (DrugBank : 49) / Drug target genes : 44 - Drug target pathways : 100

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00596037
(ClinicalTrials.gov)
August 20067/1/2008Treatment of Adults With Growth Hormone DeficiencyA Phase III, Open-label, Uncontrolled, Multicentre, Rollover Study to Assess Safety and Efficacy of LB03002 Administered Weekly in Adults With Growth Hormone DeficiencyPituitary Disorders;Adult Growth Hormone DeficiencyDrug: Growth hormone - LB03002LG Life SciencesBioPartners GmbHCompleted23 Years70 YearsBoth136Phase 3United States